Post-demographic dividend vs Tuvalu: Current health expenditure
Current health expenditure over time
- Post-demographic dividend
- Tuvalu
How they compare
Tuvalu currently reports 27.1% against 13.3% in Post-demographic dividend, a difference of 13.8%.
That makes Tuvalu's figure about 2.0 times Post-demographic dividend's.
The two have swapped places 4 times across 24 shared years of data; in 2000 it was Tuvalu ahead.
Post-demographic dividend ranks 2nd and Tuvalu ranks 1st of 47 groups.
Tuvalu has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Post-demographic dividend | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.7% | 13.1% | 2.5% | Tuvalu |
| 2010s | 12.4% | 17.0% | 4.6% | Tuvalu |
| 2020s | 13.7% | 21.2% | 7.5% | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, Post-demographic dividend or Tuvalu?
- Tuvalu, at 27.1% against 13.3% in Post-demographic dividend as of 2023.
- What is the difference in current health expenditure between Post-demographic dividend and Tuvalu?
- 13.8%, with Tuvalu ahead.
- How many years of comparable data are there for Post-demographic dividend and Tuvalu?
- 24 years are reported by both, from 2000 to 2023.
- How do Post-demographic dividend and Tuvalu rank globally for current health expenditure?
- Post-demographic dividend ranks 2nd and Tuvalu ranks 1st of 47 groups.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.